drugset / Trial / NCT00029874

Minocycline in Patients With Huntington's Disease

NCT00029874

Phase 1/2 Completed 63 enrolled FDA Office of Orphan Products Development
RandomizedDouble-blindTreatment

Summary

This is a study to determine whether treatment with minocycline is safe and tolerable in patients with Huntington's disease (HD) and whether minocycline reduces symptoms of HD in these patients.

Timeline

Start
2001-09
Primary completion
Completion
2003-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Minocycline Small molecule

Indications